Relationship of blood pressure, heart rate and behavioral mood state to norepinephrine kinetics in younger and older men following caffeine ingestion

European Journal of Clinical Nutrition

Volumn 52, Issue 11, 1998, Pages 805-812

  Arciero, Paul J ^a   Gardner, A W ^b   Benowitz, N L ^c   Poehlman, E T ^d  

^a SKIDMORE COLLEGE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF VERMONT   (United States)

Author keywords

Aging; Blood pressure; Caffeine; Mood state; Sympathetic nervous system activity

Indexed keywords

CAFFEINE; GLUCOSE; INSULIN; NORADRENALIN;

ADRENERGIC SYSTEM; ADULT; AGE; AGED; ANGER; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BODY COMPOSITION; CALORIC INTAKE; CLEARANCE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; EXERCISE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; MALE; MOOD; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; SELF EVALUATION; SYSTOLIC BLOOD PRESSURE; TENSION; UNITED STATES;

EID: 0031763926     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1600651     Document Type: Article

References (42)

1. Abraham S (1983): Height - weight tables: their sources and development. Clin. Consult. Nutr. Support. 3, 5-8.
2. Arciero PJ, Gardner AW, Calles-Escandon J, Benowitz NL & Poehlman ET (1995): Effects of caffeine ingestion on norepinephrine kinetics, fat oxidation and energy expenditure in younger and older men. Am. J. Physiol. 268, E1192-E1198.
3. Bellet S. Roman L. DeCastro O, Kim KE & Kershbaum A (1969): Effect of coffee ingestion on catecholamine release. Metabolism 18. 288-291.
4. Benowitz NL (1990): Clinical pharmacology of caffeine. Annu. Rev. Med. 41, 277-288.
5. Benowitz NL, Jacob P 3rd, Mayan H & Denaro C (1995): Sympathomimetic effects of paraxanthine and caffeine in humans. Clin. Pharmacol. Ther. 58, 684-691.
6. Blanchard J & Sawers JA (1983): Comparative pharmacokinetics of caffeine in young and elderly men. J. Pharmacokin. Biopharm. 11, 109-126.
7. Chait LD & Griffiths RR (1983): Effects of caffeine on cigarette smoking and subjective response. Clin. Pharmacol, Ther. 34, 612-622.
8. Conrad KA, Blanchard J & Trang JM (1982): Cardiovascular effects of caffeine in elderly men. J. Am. Geriatr. Soc. 30, 267-272.
9. Esler M, Jackman G, Bobik A, Kellehcr D, Jennings G, Leonard P, Skews H & Korner P (1979): Determination of norepinephrine apparent release rate and clearance in humans, Life Sci. 25, 1461-1470.
10. France C & Ditto B (1992): Cardiovascular responses to the combination of caffeine and mental arithmetic, cold pressor, and static exercise Stressors. Psychophysiology 29, 272-282.
11. Glass GV & Hopkins KD (1984): Methods in Education and Psychology, 2nd ed. Englewood Cliffs, NJ: Prentice-Hall.
12. Goldstein A, Kaiser S & Warren R (1965): Psychotropic effects of caffeine in man. II. Alertness, psychomotor coordination, and mood. J. Pharmacol. Exp. Ther. 150, 146-151.
13. Haigh RA, Harper GD, Fotherby M, Hurd J, Macdonald IA & Potter JF (1993): Duration of caffeine abstention influences the acute blood pressure responses to caffeine in elderly normotensives. Eut: J. Clin. Pharmacol. 44, 549-553.
14. Hassenfratz M & Battig K (1994): Acute dose-effect relationships of caffeine and mental performance. EEG, cardiovascular and subjective parameters. Psychopharmacology 114, 281-287.
15. Izzo JL, Ghosal A, Kwong T, Freeman RB & Jaenike JR (1983): Age and prior caffeine use alter the cardiovascular and adrenomedullary responses to oral caffeine. Am. J. Cardiol. 52, 769-773.
16. James JE (1994): Chronic effects of habitual caffeine consumption on laboratory and ambulatory blood pressure levels. J. Cardiovasc. Risk 1, 159-164.
17. Jung RT, Shetty PS, James WPT, Barrand MA & Callingham BA (1981): Caffeine: its effect on catecholamines and metabolism in lean and obese humans. Clin. Sci. Lond. 60, 527-535.
18. Lenders JWM, Morre HLC & Thien Th (1988): The effects of caffeine on the postprandial fall of blood pressure in the elderly. Age Ageing 17, 236-240.
19. Lieberman HR, Wurtman RJ, Emde GC, Roberts C & Coviella ILG (1987): The effects of low doses of caffeine on human performance and mood state. Psychopharmacology 92, 308-312.
20. McNair DM, Lorr M & Droppleman LF (1971): Profile of Mood States. San Diego: Educational and Industrial Testing Service.
21. Palmer GJ, Zeigler MG & Lake CR (1979): Response of norepinephrine and blood pressure to stress increases with age. J. Gerontol. 33, 482-487.
22. Pincomb GA, Lovallo WR, Passey RB, Whitsett TL, Silverstein SM & Wilson MF (1985): Effects of caffeine on vascular resistance, cardiac output and myocardial contractility in young men. Am. J. Cardiol. 56, 119-122.
23. Pincomb GA, Lovallo WR, McKcy BS, Sung BS, Passey RB, Everson SA & Wilson MF (1996): Acute blood pressure elevations with caffeine in men with borderline systemic hypertension. Am. J. Cardiol. 77, 270-274.
24. Poehlman ET, Després JP, Bessette H, Fontaine E, Tremblay A & Bouchard C (1985): Influence of caffeine on the resting metabolic rate of exercise-trained and inactive subjects. Med. Sci. Sports Exerc. 17, 689-694.
25. Poehlman ET, LaChance P, Tremblay A, Nadeau A, Dussault G, Thériault G, Despres J-P & Bouchard C (1989): The effect of prior exercise and caffeine ingestion on metabolic rate and hormones in young adult males. Can. J. Physiol. Pharmacol. 67, 10-16.
26. Poehlman ET, McAuliffe T, Danforth E Jr (1990): Effects of age and level of physical activity on plasma norepinephrine kinetics. Am. J. Physiol. 258, E256-E262.
27. Potter JF, Haigh RA, Harper GD, Fotherby M, Hurd S & Macdonald IA (1993): Blood pressure, plasma catecholamine and renin responses to caffeine in elderly hypertensives. J. Hum. Hypertens. 7, 273-278.
28. Rail TW (1985): Central nervous system stimulants. The methylxanthines. In: The Pharmacological Basis of Therapeutics, ed. AG Gilman et al. 7th edn, pp 589-603. New York: Macmillan.
29. Robertson D, Frolich JC, Carr RK, Watson JT, Hollifield JW, Shand DG & Gates JA (1978): Effects of caffeine on plasma renin activity, catecholamines and blood pressure. Engl. J. Med. 298, 181-186.
30. Robertson D, Wade D, Workman R, Woosley R & Oates J (1981): Tolerance to the humoral and hemodynamic effects of caffeine in man J. Clin. Invest. 67, 1111-1117.
31. Sharp DS & Benowitz NL (1990): Pharmacoepidermology of the effects of caffeine on blood pressure. Clin. Pharmacol. Ther. 47, 57-60.
32. Shi J, Benowuz NL, Denaro CP & Sheiner LB Pharmacokinetic-pharmacodynamic modeling of caffeine (1993): tolerance to pressor effects. Clin Pharmacol. Ther. 53, 6-14.
33. Siri WE (1956) The gross composition of the body. Adv. Biol. Med.
34. Smith A, Kendrick A & Maben A (1992): Effects of caffeine, lunch and alcohol on human performance, mood, and cardiovascular function. Proc. Nutr. Soc. 51, 325-333.
35. Smits P, Thien T & van't Laar A (1985):Circulatory effects of coffee in relation to the pharmacokinetics of caffeine. Am. J. Cardiol 56, 958-963.
36. Smits P, Peters G & Thien T (1986): The role of epinephrine in the circulatory effects of coffee. Clin. Pharmacol. Ther. 40, 431-437.
37. Smits P, Boekema P, De Abreu R, Thien T & van't Laar A (1987): Evidence for an antagonism between caffeine and adenosine in the human cardiovascular system. J Cardio. vasc. Pharmacol. 10, 136-143.
38. Spealman RD (1988): Psychomotor stimulant effects of methylxanthines in squirrel monkeys: relationship to adenosine antagonism. Psychopharmacology 95, 19-24.
39. Swift CG & Tiplady B (1988): The effects of age on the responses to caffeine. Psychopharmacology 94, 29-31.
40. Sung BH, Whitsett TL, Lovallo WR, al'Absi M. Pincomb GA & Wilson MF (1994): Prolonged increase in blood pressure by a single oral dose of caffeine in mildly hypertensive men. Am. J. Hypertens. 7, 755-758.
41. Taylor HL, Jacobs DR, Schucker B, Knudsen J, Leon AS & Debacker G (1978): A questionnaire for the assessment of leisure time physical activities. J. Choronic Dis. 3, 741-755.
42. Yu G, Maskray V, Jackson HD, Swift CG & Tiplady B (1991): A comparison of the central nervous system effects of caffeine and theophylline in elderly subjects. Br. J. Clin. Pharmacol. 32, 341-345.